History
30 readings since 2026-09-25Alternatives on Drugs@FDA
The actors either side of #6 of 11, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.
Sort
| # | Actor | Grade | Price / 1k | Users /30d | Success | Rating | Age | Fresh | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | — | EVT$20.00 /1k dataset-itemfair price | 23 total | — | — | 6m | aging | ||
| 2 | — | RES$3.00 /1khigh price | 23 total | — | — | 3m | aging | ||
| 3 | — | EVT$15.90 /1k itemfair price | 12 total | — | — | 46d | aging | ||
| 4 | — | EVT$4.00 /1k company-recordgood price | 12 total | — | — | 2m | aging | ||
| 5 | — | EVT$3.00 /1k medicine-eventgood price | 12 total | — | — | 3d | fresh | ||
| 6 | — | EVT$50.00 /1k drug_approvalsteep price | 12 total | — | — | 3m | fresh | This | |
| 7 | — | EVT$20.00 /1k result-itemfair price | 12 total | — | 5.0 | 5m | fresh | ||
| 8 | — | RES$2.00 /1kgood price | 11 total | — | — | 3m | fresh | ||
| 9 | — | RES$1.50 /1kgood price | 12 total | — | — | 9d | fresh | ||
| 10 | — | RES$8.80 /1ksteep price | 12 total | — | — | 2m | aging | ||
| 11 | — | RES$2.00 /1kgood price | 12 total | — | — | 2d | fresh |